^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
BI 695502 (bevacizumab biosimilar)
i
Other names: BI 695502, BI695502, BI-695502
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Boehringer Ingelheim
Drug class:
VEGF-A inhibitor
Related drugs:
